Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Sunday
Jul 05th
Home arrow Farmavita.Net Journal
Farmavita.Net Journal
Print E-mail
Market Report

datamonitor_logo.gif

Pricing and Reimbursement in Key Asia Pacific Markets

With the Asia-Pacific markets growing rapidly, they are becoming increasingly attractive for Pharma to enter. However, a number of key P&R developments and reforms are set to change the healthcare environment in the next few years, as healthcare is made more accessible to the poor and elderly.

Read more...
 
Print E-mail
Market Report

business-insights-logo.gif

Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI

‘Key Trends in Offshoring Pharmaceutical R&D' is a report published by Business Insights that evaluates the offshore R&D strategies that can reduce development times and improve productivity, with analysis of a variety of strategic partnerships, academic collaborations, and outsourcing opportunities.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Infectious Diseases Pharma Market Overview - Strategic perspectives in portfolio management

A total of 11 companies make up the top five across each of the four ID sectors, their core competencies ranging from a single disease area to generics prowess, producing a comprehensive portfolio to providing a specific offerings corresponding to highest unmet need. This report characterises the key players in each sector, and their approach to maximising their returns from a pressurised sector.

Read more...
 
Print E-mail
Press Release

datamonitor_logo.gif

World Vaccine Congress Asia: vast regional diversity requires flexibility and targeted portfolios

Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific region is incredibly diverse. This year's World Vaccine Congress Asia highlighted the enormous variation in the vaccine landscape in the region, owing to a myriad of political, cultural, economic and geographic differences.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Gastric Cancer - Targeted therapies compete for first-to-market status

Gastric cancer incidence in 2009 is forecast to be 197,000 in the seven major pharmaceutical markets (US, Japan, Germany, France, Italy, Spain, and UK). Although, the global incidence has decreased in recent years, mortality remains high, particularly in the US and Europe. Therefore, predictably a high unmet need remains for effective therapies to improve mortality.

Read more...
 
Print E-mail
Press Release

datamonitor_logo.gif

ASCO meeting 2009: current blockbusters advance standard care in new indications

Datamonitor attended the American Society of Clinical Oncology's 45th Annual Meeting in Orlando, Florida, to assess the key highlights of the conference. A number of promising presentations evaluated the potential of currently marketed agents to successfully combine with conventional chemotherapy in indications with persistent high unmet needs.

Read more...
 
Print E-mail
Life Science Article

artemisia_annua_by_lnleivan.jpg

MALARIA: AN OVERVIEW WITH HERBAL TREATMENT

The success of the antimalarial drug quinine and the discovery of artemisinin, the most potent antimalarial drug, both from plant sources, has led to the study of plants as antimalarial agents. The ethnopharmacological approach for the search of new antimalarial agents from plant sources has proved to be more predictive. In India the National Malaria Eradication Programme (NMEP), started in 1958, achieved near complete disappearance of the disease in 1960s.

The whole 34 pages article is available for download at Downloads section of Faramavita.Net

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Pharmaceuticals: Global Industry Almanac

Datamonitor's Pharmaceuticals: Extended Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gifPharmaceuticals - Top 5 Emerging Markets Industry Guide

Datamonitor's Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Pharmaceuticals - North America (NAFTA) Industry Guide

Datamonitor's Pharmaceuticals - North America (NAFTA) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the North American Free Trade Agreement (United States, Canada, and Mexico) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Pharmaceuticals - Global Group of Eight (G8) Industry Guide

Datamonitor's Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide

Datamonitor's Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, China) Pharmaceuticals industry. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.

Read more...
 
Print E-mail
Press Release

datamonitor_logo.gif

The pharmaceutical industry faces unprecedented barriers to evolution

Despite the pharmaceutical industry's evolving business model in response to growing regulatory constraints, the sector is facing unprecedented challenges caused by the economic downturn and President Obama's planned overhaul of the US healthcare system. To continue on its journey towards 'Pharma 2.0', the industry must balance the more pressing short term issues against longer term trends.

Read more...
 
Print E-mail
Press Release

datamonitor_logo.gif

APA meeting 2009: new schizophrenia products and depot formulations

The annual meeting of the American Psychiatric Association is the year's largest psychiatry event. This year's conference in San Francisco indicated that long-acting depot versions of atypical antipsychotics continue to prove useful tools in the treatment of schizophrenia. In addition, new potential market entrants reported mixed data from new oral antipsychotics.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Schizophrenia - Second generation depots protect market value

Schizophrenia is a chronic and severe mental health disorder affecting around 4.6 million schizophrenia sufferers across the seven major markets. Currently led by oral branded atypical antipsychotics, the schizophrenia market will undergo some big changes over the period 2008/2017. Prospective players can expect to face stiff competition from generic versions of all currently branded drugs.

Read more...
 
Print E-mail
Market Report

datamonitor_logo.gif

Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors

The market for CNS drugs across the 7MM was worth a substantial $95.5 billion, accounting for a 21.4% share of the total pharmaceutical market value in 2007. Despite stalling R&D productivity and the genericization of the majority of leading CNS blockbuster brands, the market continues to offer a wealth of lucrative opportunities for all types of drug manufacturer.

Read more...
 
Print E-mail
Business for Sale

API Manufacturer from India - Looking for Strategic Investor

Company was estabilished in the year 2004 by a group of technocrats from renowned Dr.Reddys Laboratories Limited. All the key personnel have expertise in their respective areas of specialization. Strong R&D, Analytical capabilities, versatile human resources and well vision management are the core competencies of the company.
Today the Group is operating with one Intermediate manufacturing unit and one API manufacturing unit both are located in Pashamylaram IDA, 25 KMs away from Hyderabad.

Read more...
 
Print E-mail
Life Science Article

shot_of_pills_by_sparktography_from_flickr.com.jpg

FORMULATION AND EVALUATION OF FLOATING TABLETS OF CEFUROXIME AXETIL

The aim of the present work was to design and development of hydrodynamically balanced tablet of cefuroxime axetil to enhance the bioavailability and therapeutic efficacy of the drug. Cefuroxime axetil is classified as a second-generation cephalosporin antibiotic and beta lactum antibiotics based on spectrum activity. Tablets are prepared by the direct compression technique by using HPMC K4M and mannitol as polymers along with sodium bi carbonate as gas generating agent. Formulation were evaluated for in vitro byoyancy and drug release study using up dissolation apparatus using 0.1N Hcl as a medium.The result indicate that floating tablets of dissolation cefuroxime axetil containg 45mg HPMC K4M provides a better option for control release action and improved bioavailability.

The whole 8 pages article is available for download at Downloads section of Faramavita.Net

 

Read more...
 
Print E-mail
Press Release

datamonitor_logo.gif

GCC healthcare: in pursuit of western standards

The healthcare sector in the Gulf Cooperation Council countries is currently undergoing a wave of reforms intended to achieve and sustain international standards of healthcare delivery. Datamonitor believes that the region has the potential to achieve these aims if it reforms healthcare insurance, develops a workforce of healthcare professionals, and accepts the use of generic pharmaceuticals.

Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 1 - 19 of 451
Advertisement
  • Networking Tips & Tricks

    Making Contacts

    Use People Finder tool from Members Manu to find other users.  Form their profile page you can send them message by means of internal messaging system. 

     
  • Latest Published
 

Featured Video

More videos ...

3D Content Cloud

Featured Events


 
pharmaci_banner_150x150.gif
 banner150x150.gif

Login to Farmavita.Net

membership is FREE
Sponsorship Opportunites

Twitter

Twitter Button from twitbuttons.com

BabelFish Translator




Click Flag for Translation

Who's Online

Farmavita.Net RSS News


Products

Click to Products

JobLine

Click here ...Post a Job for Free

Reports

Click to Reports

Events

Click to Events

CRAMS

Click to CRAMS